AI in Pharma & Healthcare: Hype or Reality?
Artificial Intelligence was long hailed as the revolutionary force that would transform the pharmaceutical and healthcare industries. But now that the initial excitement has settled, what’s left of the big promises? Which AI applications have actually made a difference, where are the biggest hurdles, and what comes next?
Find the answers in our latest whitepaper: “Current Implementation of AI Applications in the Pharmaceutical and Healthcare Industry.”
This whitepaper, created with STORM by Stanford University and edited by Dr Henriette Wolf-Klein, offers a clear and concise overview of real-world AI applications – from accelerating drug discovery and optimizing clinical trials to improving diagnostics and enabling personalized medicine.
Discover which technologies have proven themselves in practice, where the industry still faces challenges, and how ethical and regulatory questions are shaping AI adoption today. Real-life case studies and emerging trends help you separate lasting innovation from fleeting hype.
Download your copy now: “Current Implementation of AI Applications in the Pharmaceutical and Healthcare Industry.”
We hope you find the content insightful and engaging.
With this qualification course, you can continue your education in a structured manner in all CMC topics, with a technical focus on development methods, manufacturing processes, CMC documents, change management, and much more.
Attend one of our free pre-meetings to familiarise yourself with the Learning Space and the various ways in which you can interact during the event
Global regulatory requirements for drug device combination products (DDCs): You will receive a regulatory overview for the EU, the US, China, MENA, Mexico and other LATAM countries, plus you will obtain tips and tricks by (local) experts on how to speed up the approval process.
This online course offers an in-depth overview of the medical device approval process in key global markets: Regulatory strategies, approval steps and timelines for global market access, with a focus on North and South America, the Asia-Pacific region and China.
Join our one-day seminar on pharmaceutical law to gain a comprehensive overview of the key legal and regulatory principles in Germany and the EU. No prior legal knowledge is required.
Our speakers will give you tips and tricks on EP claim drafting and will show you which pitfalls to avoid.
The most important decisions of the Boards of Appeal in the field of biopharmaceuticals and biotechnology and changes in the Guidelines will be presented. The panelists will discuss, in particular, the consequences of these decisions and changes on patent practice.
The Good Pharmacovigilance Practices modules (GVP modules) by the European Medicines Agency (EMA) serve as a reference for standard practices in pharmacovigilance. This online course serves as a refresher and ensures that you are up to date with the best practices.
Join our interactive course to explore how AI is transforming pharmacovigilance. Take part in discussions, hands-on workshops, and case studies while diving into AI technologies, regulations, and their applications in drug safety. Register now to participate, share insights, and collaborate with peers!
Are you involved in the planning and conduction of clinical trials with ATMP? Do you require current knowledge on the latest GCP guideline (ICH E6 (R3)) AND ATMP-specific considerations? Then join this seminar to stay informed (including training certificate)!
This online training offers comprehensive insights into Regulatory Affairs, CMC, and GMP requirements, with a focus on the latest updates and developments in EAEU countries.
